VoIP-Pal Files Motion for Reconsideration in the Mobile Gateway Patent Cases
September 17, 2024 08:00 ET
|
Voip-Pal.Com Inc.
VoIP-Pal files a motion for reconsideraton in Mobile Gateway cases against Verizon andT-Mobile
SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial
September 09, 2024 08:00 ET
|
SINTX Technologies, Inc.
Salt Lake City, Utah, Sept. 09, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”) a leading innovator in ceramic manufacturing, today announced that it has...
Aspire Biopharma, Inc. Signs Letter of Intent to Create a Publicly Listed, Drug Delivery Company Through a Business Combination with PowerUp Acquisition Corp.
July 31, 2024 08:01 ET
|
PowerUp Acquisition Corp.
Humacao, PR and New York, NY, July 31, 2024 (GLOBE NEWSWIRE) -- Aspire Biopharma, Inc. (“Aspire” or the “Company”), a developer of a multi-faceted patent protected disruptive drug delivery mechanism...
CarbonMeta Technologies Files Provisional Patent for Tracking Captured CO2 in Concrete Using Blockchain Technology
May 28, 2024 08:30 ET
|
CarbonMeta Technologies, Inc.
Woodinville, WA, USA, May 28, 2024 (GLOBE NEWSWIRE) -- CarbonMeta Technologies Inc. (OTC PINK:COWI, “CarbonMeta”), a pioneering green technology company, today announced the filing of a...
Autonomix Announces Issuance of U.S. Patent Covering Proprietary Catheter-Based Technology for the Treatment of Cancer Related Pain
April 16, 2024 09:00 ET
|
Autonomix Medical, Inc.
Patent portfolio with over 100 patents, issued and pending, protects technology targeting a $100 billion market opportunity Company developing potential breakthrough two-fold technology that can...
Patent Allowance Granted for ALA-002 Composition by US Patent and Trademark Office
March 27, 2024 08:00 ET
|
PharmAla Biotech
PharmAla recieves Allowance from USPTO for its lead drug candidate, a next-generation MDMA composition paving the way for clinical trials
Clearmind Medicine Submits Three Additional International Patent Applications for Innovative MDMA, Ibogaine and Ketamine Compounds
February 27, 2024 07:58 ET
|
Clearmind Medicine Inc.
New patent applications build upon Clearmind’s broad IP protection in the psychedelic space Vancouver, Canada, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE:...
ProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test Development USPTO grants additional broad patents for BE-SMART
February 20, 2024 08:00 ET
|
ProPhase Labs, Inc.
Garden City, NY, Feb. 20, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics and diagnostics company, today announced important developments in the...
AgriFORCE Granted Further Patent from the USPTO Related to its FORCEGH+ Facilities
February 16, 2024 17:00 ET
|
AgriFORCE Growing Systems Ltd.
VANCOUVER, British Columbia, Feb. 16, 2024 (GLOBE NEWSWIRE) -- AgriFORCE Growing Systems Ltd. (“the Company”) (NASDAQ: AGRI; AGRIW), an intellectual property (IP) focused AgTech company, today...
Annual Anaqua Data Report Finds 2023 Patent Grant Volume Holds Steady
January 23, 2024 07:00 ET
|
Anaqua
Anaqua's 2023 analysis and infographic of USPTO Intellectual Property patent data indicates continued innovation among US-based and global companies